Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection
BackgroundLung cancer (LC) is a leading cause of cancer-deaths globally. Its lethality is due in large part to the paucity of accurate screening markers. Precision Medicine includes the use of omics technology and novel analytic approaches for biomarker development. We combined Artificial Intelligen...
Main Authors: | Ray Bahado-Singh, Kyriacos T. Vlachos, Buket Aydas, Juozas Gordevicius, Uppala Radhakrishna, Sangeetha Vishweswaraiah |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.790645/full |
Similar Items
-
Precision oncology: Artificial intelligence, circulating cell‐free DNA, and the minimally invasive detection of pancreatic cancer—A pilot study
by: Ray O. Bahado‐Singh, et al.
Published: (2023-10-01) -
Placental DNA methylation changes and the early prediction of autism in full-term newborns.
by: Ray O Bahado-Singh, et al.
Published: (2021-01-01) -
Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
by: Ray O. Bahado-Singh, et al.
Published: (2022-11-01) -
Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer’s Disease
by: Ray O. Bahado-Singh, et al.
Published: (2022-05-01) -
Alzheimer’s Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism
by: Ray O. Bahado-Singh, et al.
Published: (2023-02-01)